Oswaldo Cruz. Endemic in several Latin American countries, cases are found in rural areas, indigenous communities and the poorest suburbs from Mexico to Argentina, including parts of the Caribbean. The disease causes an estimated 14,000 deaths each year. It is estimated that 10-15 million people suffer from the disease and 100 million more, 25 per cent of the population of Latin America, are at risk of contracting it.
As a result of the increase in global migration and mobility, an increasing number of cases are being reported in the US, Europe, Australia and Japan.
The parasite is transmitted by certain species of the Triatominae 'assassin bugs' or 'kissing bugs' depending on geographical zone. The insects live in cracks in the walls and ceilings of houses made from adobe Features bricks, sticks, straw and other basic materials and emerge at night to feed on blood. When an assassin bug carrying the parasite bites a person, it deposits faeces on the skin. If the person scratches or rubs their eyes or mouth after touching the bite, the parasites can then pass into the bloodstream. If an infected person is bitten by another assassin bug, the parasite infects the insect and the cycle goes on.
In many Latin American countries, prevention programmes are being developed with the aim of reducing the presence of the insect vector, but not all of them are as effective as they could be and they have proved mostly unable to eliminate the disease.
Chagas disease can also be transmitted through blood transfusions, from mothers to children during pregnancy and, less frequently, through organ transplants or consumption of contaminated food. It is not transmitted through direct contact with infected individuals. This year marks the centenary of the discovery by the Brazilian doctor Carlos Chagas of the parasite and insect vectors which cause the disease that carries his name. A new campaign aims to boost work on this major infection in Latin America. Nigel Williams reports.
Flagging up a neglected killer
Challenging: An MSF doctor testing a child for Chagas in rural Bolivia. (Photo: MSF/Juan Carlos Tomasi.)
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The majority of people infected with T. cruzi show some sign or symptom at the time of infection and in a small number of cases acute Chagas disease can be fatal. But for the majority, the symptoms go unnoticed for years and those infected experience no further problems. It is estimated that approximately 70 per cent of these people live with the parasite without their health being affected.
Nevertheless, in the chronic phase of the disease 30 per cent will develop problems in their heart, gastrointestinal tract and central nervous system that cause irreversible damage.
There are currently only two medicines to combat Chagas disease, both of which were developed more than 35 years ago and in investigations not specifi cally aimed at Chagas disease. Neither of these drugs can be used in pregnant women but the success rate reaches almost 100 per cent in newborns and infants. However, in older children, adolescents and adults, treatment is only 60-70 per cent effective and can have multiple side effects and, therefore, has to be taken under medical supervision. This means having a weekly check-up with a trained healthcare worker.
But, as the side effects are more common in older patients, many doctors have been reluctant to use the drugs in adults, although it has now been shown that the adverse effects can be manageable.
With the limited resources available in rural areas of Latin America to treat Chagas disease, medical teams are often unable to diagnose and treat the disease. New diagnostic tests, better medicines and cure tests urgently need to be developed to deal with this illness, say MSF.
Currently, MSF uses a rapid diagnostic test to detect cases. But, following WHO recommendations, all positive tests need to be confi rmed with two conventional laboratory serological assays. If there is any discrepancy between the two tests, a third laboratory test must be used to obtain a reliable result.
In areas such as rural Bolivia, where the incidence of the disease is high, the ideal would be to have a highly sensitive and specifi c rapid diagnostic test which would reveal whether the patient was infected or not in a short space of time and would not require specialised laboratories.
MSF says the Drugs for Neglected Diseases initiative (DNDi), of which it is a founder member, is working on possible alternative treatments to the two currently available. But these are a long way from being available and at low cost, and their effectiveness has yet to be demonstrated.
"There is an urgent need to develop new, less toxic, medicines which require a shorter course of treatment, are effective in the acute and chronic phases of the disease in both adults and children, and are safe for pregnant women," says MSF.
MSF also highlights the major problem of determining whether treatment has been effective. "The current serological methods can take decades," it says. "PCR techniques, based on genetic information, have a low sensitivity and specifi city for parasites, and they are only available in some research centres," says MSF. "Development of rapid treatment tests which allow for the effectiveness of treatment to be measured and cure to be confi rmed in the fi rst two years after treatment for all age groups is essential." MSF also believes the research climate needs to change for neglected diseases. In 2006 the WHO Commission for Intellectual Property Rights, Innovation and Health recognised the failure of current incentives and fi nancing mechanisms for neglected diseases. "There is a need to identify new incentives for research and development and the fi nal price of health products to obtain better and new diagnostics and treatments," says MSF.
We all hope we are capable of making rational choices and we particularly expect it from others, especially those in positions of power and infl uence. Indeed, economic models of animal behaviour assume that decision-makers are rational, meaning that they assess options according to intrinsic fi tness value, and not by comparison to available alternatives.
However, unsurprisingly, this expectation frequently fails, but the signifi cance of irrational behaviour remains controversial. One possibility is that irrationality arises from cognitive constraints that necessitate short cuts like comparative evaluation of available choices. If so, the study of whether and when irrationality occurs can illuminate cognitive mechanisms.
A basic assumption of behavioural ecology is that animals act to maximise their fi tness. To do so, a rational decision-maker must consistently value each option on the basis of its contribution to utility. In a biological setting, rationality implies that decision-making animals should assign value according to an option's net fi tness benefi ts. For example, an animal that prefers food type A to type B should not switch preference to B if a third type C is also made available.
However, experiments with humans and animals reveal widespread irrationality which appears to cast doubt on the idea that individuals maximise either utility or fi tness.
Recent theoretical work also shows that even optimal brains of high complexity will be error-prone in the information-rich environments typical of real animals, write researchers Susan Edwards and Stephen Pratt.
In a new study, Edwards at Princeton University and Pratt at Arizona State University, reporting in the Proceedings of the Royal Society B (published online), have looked at the collective decisions of insect societies.
They tested for irrationality in colonies of Temnothorax ants choosing between two nest sites that varied in attributes, such that neither nest site was clearly superior. In similar situations, individual animals show irrational changes in preference when a third relatively unattractive option is introduced.
Edwards and Pratt's ants are eusocial insect colonies, where sterile workers advance their inclusive fi tness largely through cooperative rearing of the queen's offspring. As a result, selection has acted at the level of the whole colony to shape A new study suggests ant colonies can avoid irrational changes in preference that can be shown by individual animals and humans. Nigel Williams reports.
Collective rationality
